National Center for Complementary & Alternative Medicine; Notice of Closed Meeting, 48576-48577 [E9-22739]
Download as PDF
<![CDATA[
48576
Federal Register / Vol. 74, No. 183 / Wednesday, September 23, 2009 / Notices
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Deafness and Other Communication
Disorders Special Emphasis Panel; CDRC
Member Conflicts.
Date: October 27, 2009.
Time: 11:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6120
Executive Blvd., Rockville, MD 20852,
(Telephone Conference Call).
Contact Person: Christine A. Livingston,
PhD, Scientific Review Officer, Division of
Extramural Activities, National Institutes of
Health/NIDCD, 6120 Executive Blvd.—MSC
7180, Bethesda, MD 20892, (301) 496–8683,
livingsc@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.173, Biological Research
Related to Deafness and Communicative
Disorders, National Institutes of Health, HHS)
Dated: September 17, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–22978 Filed 9–22–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of
Closed Meetings
mstockstill on DSKH9S0YB1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Special Emphasis Panel; Pathogenesis
of Age-Dependent CNS Degeneration.
Date: October 7, 2009.
Time: 12 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Building, 7201 Wisconsin Avenue,
2C212, Bethesda, MD 20892 (Telephone
Conference Call).
VerDate Nov<24>2008
17:06 Sep 22, 2009
Jkt 217001
Contact Person: Alexander Parsadanian,
PhD, Scientific Review Officer, National
Institute on Aging, Gateway Building 2C/212,
7201 Wisconsin Avenue, Bethesda, MD
20892, 301–402–7703,
PARSADANIANA@NIA.NIH.GOV.
Name of Committee: National Institute on
Aging Special Emphasis Panel;
Mitochondrial Function in Longevity I.
Date: November 10, 2009.
Time: 11:30 a.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Building, 7201 Wisconsin Avenue,
2C212, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Bita Nakhai, PhD,
Scientific Review Officer, Scientific Review
Branch, National Institute on Aging, Gateway
Bldg., 2C212, 7201 Wisconsin Avenue,
Bethesda, MD 20814, 301–402–7701,
nakhaib@nia.nih.gov.
Name of Committee: National Institute on
Aging Special Emphasis Panel; MDS 1
Review.
Date: November 20, 2009.
Time: 12 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Building, 7201 Wisconsin Avenue,
2C212, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Bita Nakhai, PhD,
Scientific Review Officer, Scientific Review
Branch, National Institute on Aging, Gateway
Bldg., 2C212, 7201 Wisconsin Avenue,
Bethesda, MD 20814, 301–402–7701,
nakhaib@nia.nih.gov.
Name of Committee: National Institute on
Aging Special Emphasis Panel; Genetics of
Osteoporosis.
Date: November 24, 2009.
Time: 11 a.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Building, 7201 Wisconsin Avenue,
2C212, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Rebecca J. Ferrell, PhD,
Scientific Review Officer, National Institute
on Aging, Gateway Building 2C212, 7201
Wisconsin Avenue, Bethesda, MD 20892,
301–402–7703, ferrellrj@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
Dated: September 17, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–22980 Filed 9–22–09; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00059
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Task Force on Community Preventive
Services
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC) announce
the following meeting:
Name: Task Force on Community
Preventive Services Meeting.
Times and Dates: 8 a.m.–5:30 p.m. EST,
October 14, 2009. 8 a.m.–1 p.m. EST, October
15, 2009.
Place: Centers for Disease Control and
Prevention, 2500 Century Parkway, Room
1200/1201, Atlanta, Georgia 30345.
Status: Open to the public, limited only by
space available.
Purpose: The mission of the Task Force is
to develop and publish the Guide to
Community Preventive Services (Community
Guide), which is based on the best available
scientific evidence and current expertise
regarding essential public health and what
works in the delivery of those services.
Topics:
—Interventions to increase screening for
breast, cervical and colorectal cancer and
of interventions to increase vaccination
rates: Updates of reviews.
—Assessing effectiveness of interventions to
increase physical activity.
—Assessing the scope of reviews of
interventions to reduce inequalities in
health outcomes.
Agenda items are subject to change as
priorities dictate.
Contact person for additional information:
Freda Parker, Community Guide Branch,
Coordinating Center for Health Information
and Service, National Center for Health
Marking, Division of Health Communication
and Marketing, 1600 Clifton Road, M/S E–69,
Atlanta, GA 30333, phone: 404.498.1119.
Dated: September 17, 2009.
Tanja Popovic,
Chief Science Officer, Centers for Disease
Control and Prevention.
[FR Doc. E9–22885 Filed 9–22–09; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center for Complementary &
Alternative Medicine; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the Board
of Scientific Counselors, National
E:\FR\FM\23SEN1.SGM
23SEN1
Federal Register / Vol. 74, No. 183 / Wednesday, September 23, 2009 / Notices
Center for Complementary and
Alternative Medicine.
The meeting will be closed to the
public as indicated below in accordance
with the provisions set forth in section
552b(c)(6), Title 5 U.S.C., as amended
for the review, discussion, and
evaluation of individual intramural
programs and projects conducted by the
National Center for Complementary &
Alternative Medicine, including
consideration of personnel
qualifications and performance, and the
competence of individual investigators,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
mstockstill on DSKH9S0YB1PROD with NOTICES
Name of Committee: Board of Scientific
Counselors, National Center for
Complementary and Alternative Medicine.
Date: October 16, 2009.
Time: 10 a.m. to 4 p.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: National Institutes of Health,
Building 50, 50 South Drive, Room 1328/
1334, Bethesda, MD 20892.
Contact Person: Robert B. Nussenblatt, MD,
Acting Scientific And Clinical Director,
Division of Intramural Research, NCCAM
National Institutes of Health, Bethesda, MD
20892.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.213, Research and Training
in Complementary and Alternative Medicine,
National Institutes of Health, HHS)
Dated: September 11, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–22739 Filed 9–22–09; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Neurological Sciences
Training Initial Review Group; NST–1
Subcommittee.
Date: October 5–6, 2009.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Fairmont Washington, DC, 2401
M Street, NW., Washington, DC 20037.
Contact Person: Raul A. Saavedra, PhD,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Research,
NINDS/NIH/DHHS, NSC; 6001 Executive
Blvd., Ste. 3208, Bethesda, MD 20892–9529,
301–496–9223, saavedrr@ninds.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS)
Dated: September 17, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–22979 Filed 9–22–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meetings
BILLING CODE 4140–01–M
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
VerDate Nov<24>2008
17:06 Sep 22, 2009
Jkt 217001
PO 00000
Frm 00060
Fmt 4703
Sfmt 4703
48577
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; The NIDDK–KUH
Fellowship Review Committee.
Date: October 16, 2009.
Time: 10 a.m. to 12 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892, (Telephone
Conference Call)
Contact Person: Xiaodu Guo, MD, PhD,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 761, 6707 Democracy Boulevard,
Bethesda, MD 20892–5452, (301) 594–4719,
guox@extra.niddk.nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; Pulse Wave Velocity
in CKD Ancillary Studies.
Date: October 23, 2009.
Time: 3 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892, (Telephone
Conference Call)
Contact Person: Michele L. Barnard, PhD,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 753, 6707 Democracy Boulevard,
Bethesda, MD 20892–2542, (301) 594–8898,
barnardm@extra.niddk.nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; Inflammation and
Obesity.
Date: November 2, 2009.
Time: 11:30 a.m. to 12:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892, (Telephone
Conference Call)
Contact Person: Maria E. Davila-Bloom,
PhD, Scientific Review Officer, Review
Branch, DEA, NIDDK, National Institutes of
Health, Room 758, 6707 Democracy
Boulevard, Bethesda, MD 20892–5452, (301)
594–7637, davilabloomm@extra.niddk.nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; Inflammatory Bowel
Disease.
Date: November 20, 2009.
Time: 8:30 a.m. to 2 p.m.
E:\FR\FM\23SEN1.SGM
23SEN1
]]>Agencies
[Federal Register Volume 74, Number 183 (Wednesday, September 23, 2009)]
[Notices]
[Pages 48576-48577]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-22739]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Center for Complementary & Alternative Medicine; Notice
of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of a meeting of the
Board of Scientific Counselors, National
[[Page 48577]]
Center for Complementary and Alternative Medicine.
The meeting will be closed to the public as indicated below in
accordance with the provisions set forth in section 552b(c)(6), Title 5
U.S.C., as amended for the review, discussion, and evaluation of
individual intramural programs and projects conducted by the National
Center for Complementary & Alternative Medicine, including
consideration of personnel qualifications and performance, and the
competence of individual investigators, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Board of Scientific Counselors, National
Center for Complementary and Alternative Medicine.
Date: October 16, 2009.
Time: 10 a.m. to 4 p.m.
Agenda: To review and evaluate personal qualifications and
performance, and competence of individual investigators.
Place: National Institutes of Health, Building 50, 50 South
Drive, Room 1328/1334, Bethesda, MD 20892.
Contact Person: Robert B. Nussenblatt, MD, Acting Scientific And
Clinical Director, Division of Intramural Research, NCCAM National
Institutes of Health, Bethesda, MD 20892.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has instituted stringent
procedures for entrance onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles will be inspected
before being allowed on campus. Visitors will be asked to show one
form of identification (for example, a government-issued photo ID,
driver's license, or passport) and to state the purpose of their
visit.
(Catalogue of Federal Domestic Assistance Program Nos. 93.213,
Research and Training in Complementary and Alternative Medicine,
National Institutes of Health, HHS)
Dated: September 11, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-22739 Filed 9-22-09; 8:45 am]
BILLING CODE 4140-01-M
